There are more than 230 kinds of anti-cancer drugs in the current national medical insurance directory, covering more than 20 common cancers such as lung cancer, breast cancer, and gastric cancer, involving chemotherapy drugs, targeted treatment drugs, immunotherapy drugs, etc. In addition to drugs that directly treat cancer, the national medical insurance catalog also covers other necessary adjuvant drugs. For example, tumor chemotherapy drugs often bring side effects such as vomiting, decreased white blood cells, and platelets. Corresponding potent antiemetic drugs, long-acting white blood boosting injections, and other drugs are also included in the national medical insurance catalog, reducing the medical cost burden of patients with major diseases such as cancer. Since its establishment, the National Healthcare Security Administration has regularly adjusted the list of medical insurance drugs every year, promoting more new and good drugs to be included in medical insurance as soon as possible. Since the 14th Five Year Plan, a total of 402 drugs have been included in the national medical insurance list. Among them, some new anti-cancer drugs were included in the catalog within less than a year of approval, continuously improving the level of protection for patients with major diseases such as cancer. (New Society)